185 related articles for article (PubMed ID: 16501105)
1. Exploring the DNA binding interactions of the Kaposi's sarcoma-associated herpesvirus lytic switch protein by selective amplification of bound sequences in vitro.
Ziegelbauer J; Grundhoff A; Ganem D
J Virol; 2006 Mar; 80(6):2958-67. PubMed ID: 16501105
[TBL] [Abstract][Full Text] [Related]
2. The lytic switch protein of KSHV activates gene expression via functional interaction with RBP-Jkappa (CSL), the target of the Notch signaling pathway.
Liang Y; Chang J; Lynch SJ; Lukac DM; Ganem D
Genes Dev; 2002 Aug; 16(15):1977-89. PubMed ID: 12154127
[TBL] [Abstract][Full Text] [Related]
3. Characterization of Kaposi's sarcoma-associated herpesvirus (KSHV) K1 promoter activation by Rta.
Bowser BS; Morris S; Song MJ; Sun R; Damania B
Virology; 2006 May; 348(2):309-27. PubMed ID: 16546233
[TBL] [Abstract][Full Text] [Related]
4. RBP-J (CSL) is essential for activation of the K14/vGPCR promoter of Kaposi's sarcoma-associated herpesvirus by the lytic switch protein RTA.
Liang Y; Ganem D
J Virol; 2004 Jul; 78(13):6818-26. PubMed ID: 15194757
[TBL] [Abstract][Full Text] [Related]
5. Direct interactions of Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 ORF50/Rta protein with the cellular protein octamer-1 and DNA are critical for specifying transactivation of a delayed-early promoter and stimulating viral reactivation.
Carroll KD; Khadim F; Spadavecchia S; Palmeri D; Lukac DM
J Virol; 2007 Aug; 81(16):8451-67. PubMed ID: 17537858
[TBL] [Abstract][Full Text] [Related]
6. Lytic but not latent infection by Kaposi's sarcoma-associated herpesvirus requires host CSL protein, the mediator of Notch signaling.
Liang Y; Ganem D
Proc Natl Acad Sci U S A; 2003 Jul; 100(14):8490-5. PubMed ID: 12832621
[TBL] [Abstract][Full Text] [Related]
7. DNA binding by Kaposi's sarcoma-associated herpesvirus lytic switch protein is necessary for transcriptional activation of two viral delayed early promoters.
Lukac DM; Garibyan L; Kirshner JR; Palmeri D; Ganem D
J Virol; 2001 Aug; 75(15):6786-99. PubMed ID: 11435557
[TBL] [Abstract][Full Text] [Related]
8. Kaposi's Sarcoma-associated herpesvirus lytic switch protein stimulates DNA binding of RBP-Jk/CSL to activate the Notch pathway.
Carroll KD; Bu W; Palmeri D; Spadavecchia S; Lynch SJ; Marras SA; Tyagi S; Lukac DM
J Virol; 2006 Oct; 80(19):9697-709. PubMed ID: 16973574
[TBL] [Abstract][Full Text] [Related]
9. Amplification of the Kaposi's sarcoma-associated herpesvirus/human herpesvirus 8 lytic origin of DNA replication is dependent upon a cis-acting AT-rich region and an ORF50 response element and the trans-acting factors ORF50 (K-Rta) and K8 (K-bZIP).
AuCoin DP; Colletti KS; Cei SA; Papousková I; Tarrant M; Pari GS
Virology; 2004 Jan; 318(2):542-55. PubMed ID: 14972523
[TBL] [Abstract][Full Text] [Related]
10. Kaposi's sarcoma-associated herpesvirus (KSHV) Rta and cellular HMGB1 proteins synergistically transactivate the KSHV ORF50 promoter.
Harrison SM; Whitehouse A
FEBS Lett; 2008 Sep; 582(20):3080-4. PubMed ID: 18692049
[TBL] [Abstract][Full Text] [Related]
11. Kaposi's sarcoma-associated herpesvirus reactivation is regulated by interaction of latency-associated nuclear antigen with recombination signal sequence-binding protein Jkappa, the major downstream effector of the Notch signaling pathway.
Lan K; Kuppers DA; Robertson ES
J Virol; 2005 Mar; 79(6):3468-78. PubMed ID: 15731241
[TBL] [Abstract][Full Text] [Related]
12. Functional analysis of Kaposi's sarcoma-associated herpesvirus RTA in an RTA-depressed cell line.
Nishimura K; Ueda K; Sakakibara S; Ishikawa K; Chen J; Okuno T; Yamanishi K
J Hum Virol; 2001; 4(6):296-305. PubMed ID: 12082396
[TBL] [Abstract][Full Text] [Related]
13. Identification of the DNA sequence interacting with Kaposi's sarcoma-associated herpesvirus viral interferon regulatory factor 1.
Park J; Lee MS; Yoo SM; Jeong KW; Lee D; Choe J; Seo T
J Virol; 2007 Nov; 81(22):12680-4. PubMed ID: 17855527
[TBL] [Abstract][Full Text] [Related]
14. Accumulation of heterochromatin components on the terminal repeat sequence of Kaposi's sarcoma-associated herpesvirus mediated by the latency-associated nuclear antigen.
Sakakibara S; Ueda K; Nishimura K; Do E; Ohsaki E; Okuno T; Yamanishi K
J Virol; 2004 Jul; 78(14):7299-310. PubMed ID: 15220403
[TBL] [Abstract][Full Text] [Related]
15. Genome-wide identification of binding sites for Kaposi's sarcoma-associated herpesvirus lytic switch protein, RTA.
Chen J; Ye F; Xie J; Kuhne K; Gao SJ
Virology; 2009 Apr; 386(2):290-302. PubMed ID: 19233445
[TBL] [Abstract][Full Text] [Related]
16. Essential role of RBP-Jkappa in activation of the K8 delayed-early promoter of Kaposi's sarcoma-associated herpesvirus by ORF50/RTA.
Wang Y; Yuan Y
Virology; 2007 Mar; 359(1):19-27. PubMed ID: 17055026
[TBL] [Abstract][Full Text] [Related]
17. Transcriptional regulation of the open reading frame 35 encoded by Kaposi's sarcoma-associated herpesvirus.
Masa SR; Lando R; Sarid R
Virology; 2008 Feb; 371(1):14-31. PubMed ID: 17963810
[TBL] [Abstract][Full Text] [Related]
18. Cooperation between viral interferon regulatory factor 4 and RTA to activate a subset of Kaposi's sarcoma-associated herpesvirus lytic promoters.
Xi X; Persson LM; O'Brien MW; Mohr I; Wilson AC
J Virol; 2012 Jan; 86(2):1021-33. PubMed ID: 22090118
[TBL] [Abstract][Full Text] [Related]
19. The transcriptional repressor K-RBP modulates RTA-mediated transactivation and lytic replication of Kaposi's sarcoma-associated herpesvirus.
Yang Z; Wood C
J Virol; 2007 Jun; 81(12):6294-306. PubMed ID: 17409159
[TBL] [Abstract][Full Text] [Related]
20. Identification and characterization of the promoter region of Kaposi's sarcoma-associated herpesvirus ORF11.
Chen L; Park MS
Virus Res; 2009 Jun; 142(1-2):160-8. PubMed ID: 19428749
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
